Mass. blood collection device firm obtains $1.9M

03/22/2013 | American City Business Journals

Seventh Sense Biosystems has obtained $1.9 million in a round of debt funding from five unnamed investors. Last summer, the Cambridge, Mass.-based startup also raised $10 million in a Series A round that it said would finance the development and commercialization of its Touch Activated Phlebotomy device, its first blood collection product.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ